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Thymic Selection by a Single MHC/Peptide Ligand:
Autoreactive T Cells Are Low-Affinity Cells
loaded only with class II±associated invariant chain pep-
tides (CLIP) (Fung-Leung et al., 1996; Martin et al., 1996;
Miyazaki et al., 1996). In both types of single-ligand
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mice, considerable numbers (20%±50% of normal) ofThe Scripps Research Institute
polyclonal CD41 cells were produced, implying that a10550 North Torrey Pines Road
single ligand is capable of selecting a large repertoireLa Jolla, California 92037
of T cells (Fung-Leung et al., 1996; Ignatowicz et al.,²The Medical Research Center
1996; Martin et al., 1996; Miyazaki et al., 1996; FukuiSeoul National University
et al., 1997). Nevertheless, the CD41 cell repertoire ofSeoul 110-744
single-ligand mice was found to be somewhat less di-Korea
verse than in normal mice (Sant'Angelo et al., 1997; Surh
et al., 1997; Tourne et al., 1997).
The CD41 cells generated in single-ligand mice were
Summary unusual in that, despite being tolerant to autologous
H2-M2 APC, the majority (65%±75%) of the cells were
In H2-M2 mice, the presence of a single peptide, CLIP, strongly reactive to wild-type syngeneic (B6) APC, i.e.,
bound to MHC class II molecules generates a diverse to APC expressing MHC class II molecules loaded with
repertoire of CD41 cells. In these mice, typical self- a normal array of self-peptides (Fung-Leung et al., 1996;
peptides are not bound to class II molecules, with the Ignatowicz et al., 1996; Martin et al., 1996; Miyazaki et al.,
result that a very high proportion of H2-M2 CD41 cells 1996; Fukui et al., 1997). This finding is to be expected,
are responsive to the various peptides displayed on because in single-ligand mice the failure of class II MHC
normal MHC-compatible APC. We show here, how- molecules to bind normal self-peptides presumably pre-
ever, that such ªselfº reactivity is controlled by low- cludes self tolerance induction to these peptides. In line
affinity CD41 cells. These cells give spectacularly high with this idea, repopulating irradiated H2-M2 mice with
proliferative responses but are virtually unreactive in wild-type B6 BM cells generated H2-M2 CD41 cells that
certain other assays, e.g., skin graft rejection; re- were fully tolerant of wild-type APC (Surh et al., 1997).
sponses to MHC alloantigens, by contrast, are intense Significantly, however, the formation of CD41 cells in
in all assays. Possible explanations for why thymic B6→H2-M2 chimeras was reduced by 70%±80%, pre-
selection directed to a single peptide curtails self sumably reflecting prominent intrathymic negative se-
specificity without affecting alloreactivity are dis- lection to the normal array of self-peptides on wild-type
cussed. APC (Surh et al., 1997; Tourne et al., 1997).
In this paper, we show that CD41 cells in H2-M2 mice
display strong reactivity to wild-type syngeneic APCIntroduction
by several different parameters, including induction of
certain types of GVHD on adoptive transfer. Surprisingly,T cells develop in the thymus through a combined pro-
however, even after priming, H2-M2 mice fail to rejectcess of positive and negative selection based on the
wild-type B6 skin grafts, despite causing rapid rejectionaffinity of the TCR toward the self MHC molecules ex-
of third-party MHC class II±different grafts. Evidencepressed on epithelial cells and antigen-presenting cells
is presented that such split-tolerance reflects that the(APC) (Bevan, 1977; Kappler et al., 1987; Sprent et al.,
reactivity of H2-M2 CD41 cells for wild-type APC is con-1988; von Boehmer, 1990; Jameson et al., 1995; Benoist
trolled by low-affinity cells, high-affinity cells havingand Mathis, 1997). The MHC molecules mediating thy-
been deleted (or not formed) during ontogeny.mic selection are presumed to be loaded with a diverse
spectrum of self-peptides, and the contribution of each
Resultsdistinct MHC/peptide complex to the selection of the
mature T cell repertoire has recently been the subject
In Vitro Responses of H2-M2 CD41 Cellsof intense interest (Hogquist et al., 1994; Benoist and
Consistent with previous findings (Fung-Leung et al.,Mathis, 1997; Bevan, 1997; Marrack and Kappler, 1997;
1996; Surh et al., 1997), wild-type syngeneic B6 andJameson and Bevan, 1998). To address this issue, we
allogeneic bm12 APC induced similar levels of prolifera-and others have generated strains of mice that express
tion of purified H2-M2 CD41 cells in vitro (Figure 1A):MHC class II molecules loaded with only a single species
these responses were much stronger and occurred withof peptides. These single-ligand mice were produced
faster kinetics than the control B6 CD41 cell responseeither by the expression of transgenic MHC class II mol-
to allogeneic bm12 APC (Figure 1A). Early in culture (dayecules preloaded with a peptide by covalent linkage
2), MLR of H2-M2 CD41 cells were stronger to B6 than(Ignatowicz et al., 1996; Fukui et al., 1997) or by deleting
to bm12.H2-M molecules by homologous recombination; lack of
Examining cytokine synthesis in the cultures showedH2-M molecules leads to expression of H2-Ab molecules
that bm12 APC elicited significant production of IL-2,
IL-3, IL-4, and IFNg (Figure 1A). This applied to both
normal B6 CD41 cells and H2-M2 CD41 cells. Surpris-³ To whom correspondence should be addressed (e-mail: csurh@
scripps.edu). ingly, however, the intense proliferative response of
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Figure 1. Responses and Inhibition of H2-M2
CD41 Cells to B6 versus bm12 APC
(A) MLR and cytokine production by H2-M2
CD41 cells upon stimulation with B6 versus
bm12 APC. Purified CD41 cells (1.5 3 105/
well) from young adult H2-M2 (left column)
or B6 (right column) mice were cultured with
irradiated B6 or bm12 T-depleted stimulator
spleen cells (7 3 105/well) for 2±4 days as
described in Experimental Procedures. To
measure proliferation, cultures were pulsed
with 3H-TdR for 8 hr prior to harvest. To mea-
sure cytokine production by the responding
T cells, supernatants from the wells were har-
vested and analyzed for the presence of IL-2,
IL-4, IFNg, and IL-3 by ELISA as described in
Experimental Procedures. Values are aver-
ages of triplicate cultures.
(B) Capacity of anti-H2-A, anti-CD4, or anti-
TCR MAbs to inhibit MLR of H2-M2 CD41
cells to B6 versus bm12 APC. Purified H2-M2
CD41 cells (1.5 3 105/well) were incubated
with irradiated B6 or bm12 T-depleted stimu-
lator spleen cells (7 3 105/well) for 3 days in
the presence of titrated concentrations of
Y3P (anti-H2-Ab) or GK1.5 (anti-CD4) as de-
scribed in Experimental Procedures; for inhi-
bition with anti-TCR MAb, Vb8-transgenic
H2-M2 CD41 cells were cultured in the pres-
ence of titrating amounts of Vb8-specific IgM
MAb MR5-7, which does not induce prolifera-
tion of Vb81 T cells in soluble form. Cultures
were pulsed with 3H-TdR for 16±18 hr prior
to harvest. Data are expressed as percentage
of cpm observed in cultures without any inhibiting MAb: 86,136 and 73,201 for Vb81 H2-M2 CD41 cell responses to B6 and bm12 APC,
respectively, and 143,678 and 146,056 for nontransgenic H2-M2 CD41 cell responses to B6 and bm12 APC, respectively. All values are
averages of triplicate cultures.
H2-M2 CD41 cells to wild-type B6 APC was associated inhibit the response of H2-M2 CD41 cells to B6 APC was
appreciably (3- to 5-fold) lower than for the response towith only low synthesis of IL-2, IL-4, and IFNg; IL-3 pro-
duction was comparable to bm12-stimulated H2-M2 bm12 APC.
Collectively, these results from three different assaysCD41 cells.
The low levels of IL-2, IL-4, and IFNg elicited by B6 systems suggest that the average affinity/avidity of
H2-M2 CD41 for wild-type B6 APC is substantially lowerAPC could reflect that H2-M2 CD41 cells react to wild-
type B6 APC with lower affinity than to bm12 APC. In than for bm12 APC.
support of this idea, the proliferative response of H2-M2
CD41 cells to B6 APC was more easily blocked by anti- In Vivo Responses
H2-A or anti-CD4 MAbs than the response to bm12 APC To compare the response of H2-M2 CD41 cells to B6
(Figure 1B, top and middle). The doses of anti-H2-A or versus bm12 APC in vivo, we examined induction of
anti-CD4 MAbs required to achieve inhibition to 50% of GVHD and skin graft rejection. For GVHD induction,
the maximum proliferation were about 10-fold lower for three different assays were used.
the cells responding to B6 APC than for the cells re-
sponding to bm12 APC. As expected, high concentra-
Simonsen Assaytions of anti-H2-A MAb Y3P, which blocks equally the
Transferring T cells to unirradiated H2-different neonatalresponse of a third party BALB/c CD41 cells to both
mice leads to a dose-dependent increase in the size ofH2-Ab and H2-Abm12 molecules (data not shown), com-
the spleen, presumably reflecting stimulation of hostpletely inhibited responses of H2-M2 CD41 cells to both
hemopoietic cells by cytokines such as IL-3 elicited byB6 and bm12 APC. With the anti-CD4 MAb GK1.5, how-
the GVH reaction (Simonsen, 1962; Elie and Lapp, 1976);ever, high concentrations of anti-CD4 MAb completely
splenomegaly is most prominent at about day 10 post-blocked the response to B6 APC but reduced the re-
transfer and is not seen with transfer of syngeneic Tsponse to bm12 APC by only 70% (Figure 1B, middle),
cells. As shown in Table 1, even small doses of H2-M2indicating that the response to bm12 was partly CD4
CD41 cells induced prominent splenomegaly whenindependent.
transferred to either B6 or bm12 neonatal mice. TheSimilar evidence came from studies on the blocking
magnitude of splenomegaly elicited by H2-M2 CD41effect of anti-TCR MAb (Figure 1B, bottom). For these
cells was similar in both B6 and bm12 hosts. Controlexperiments, we used the Vb8-specific IgM MAb,
normal B6 or bm12 CD41 cells induced splenomegaly inMR5-7, and CD41 cells from TCR Vb8-transgenic H2-M2
bm12 and B6 hosts, respectively, but not in autologousmice (Sant'Angelo et al., 1997). As for the above re-
agents, the concentration of anti-TCR MAb required to hosts.
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Table 1. Induction of Splenomegaly in Neonatal B6 and bm12 Hosts by H2M2CD41 Cells
Spleen/Body Weight
Experiment Donor Cells Hosts n (31023) Splenomegaly Index
1 1 3 106 B6 CD41 B6 2 3.78 6 0.08 (1.00)
1 3 106 H2-M2 CD41 B6 2 9.83 6 1.37 2.60 6 0.37
2 1 3 106 B6 CD41 B6 2 2.93 6 0.02 (1.00)
1 3 106 H2-M2 CD41 B6 3 9.93 6 1.20 3.39 6 0.41
2 3 105 H2-M2 CD41 B6 3 10.02 6 1.53 3.41 6 0.52
1 3 106 bm12 CD41 B6 3 9.74 6 0.50 3.32 6 0.17
2 3 105 bm12 CD41 B6 3 9.09 6 1.07 3.10 6 0.35
3 2 3 106 bm12 CD41 bm12 2 4.72 6 0.51 (1.00)
2 3 106 H2-M2 CD41 bm12 2 16.53 6 4.94 3.50 6 1.05
2 3 106 B6 CD41 bm12 2 16.69 6 1.44 3.54 6 0.30
4 1 3 106 bm12 CD41 bm12 2 4.35 6 0.28 (1.00)
1 3 106 H2-M2 CD41 bm12 2 14.76 6 0.83 3.40 6 0.19
Purified donor CD41 cells were i.v. injected into neonatal B6 or bm12 (day 2±4) hosts and the spleen and body weights measured 10 days
later. Splenomegaly indices were calculated as experimental mouse spleen-to-body weight ratio divided by the control mouse spleen-to-
body weight ratio, where the control mice received autologous CD41 cells.
BM Aplasia 1994), injecting H2-M2 CD41 cells together with donor
BM cells prevented death from hemopoietic failure andWhen purified CD41 cells are transferred to sublethally
irradiated (600 cGy) class II±different hosts, the donor instead led to splenomegaly (relative to mice given sub-
lethal irradiation alone); here, H2-M2 CD41 cells wereT cells destroy host stem cells in the marrow and cause
death from hemopoietic failure within 3 weeks (Sprent more potent than bm12 CD41 cells in inducing spleno-
megaly in B6 hosts.et al., 1990, 1994); stem cell destruction by CD41 cells
is class II±restricted and applies only to host and not Collectively, the results show that, either in wild-type
B6 or bm12 hosts, H2-M2 CD41 cells induced strongdonor stem cells. As shown in Table 2, transferring
H2-M2 CD41 cells (without BM cells) to sublethally irra- class II±restricted destruction of host stem cells and
rapid death from hemopoietic failure; with donor BM,diated B6 or bm12 hosts caused marked BM aplasia
when the mice were killed and autopsied on day 14 these cells were stimulated by the GVHD reaction, thus
resulting in splenomegaly.postinjection; leaving the hosts for longer periods led to
death within 3 weeks. Titration experiments with limiting The marked B6 reactivity of H2-M2 CD41 cells seen
in the above GVHD assays are in striking contrast to thedoses of T cells showed that H2-M2 CD41 cells were
as potent as allogeneic bm12 CD41 cells in inducing complete absence of B6 reactivity in the two assays
described below.BM aplasia in B6 hosts (Table 2). A similar pattern of
BM aplasia followed by death occurred when control
normal B6 CD41 cells were transferred to irradiated Lethal GVHD from Gut Damage
When CD41 cells are transferred to class II±differentbm12 hosts; with these cells, no pathology was seen in
syngeneic B6 hosts (data not shown). As found pre- hosts given heavy irradiation (1000 cGy), cotransfer of
donor BM cells fails to prevent mortality, and the hostsviously for the B6→bm12 combination (Sprent et al.,
Table 2. Induction of Marrow Aplasia in Lightly Irradiated Adult B6 Hosts by H2-M2 CD41 Cells
Hosts BM Counts Spleen Lethal Mean Survival
Experiment Donor Cells (600cGy) n (3106) Weight (mg) GVHD Time (d)
1 none B6 4 19.7 6 1.8 72 6 5 0/4 .100
106 bm12 CD41 B6 4 0.6 6 0.3 27 6 4 4/4 19 6 1
106 H2-M2 CD41 bm12 4 0.8 6 0.3 50 6 7 4/4 18 6 1
106 H2-M2 CD41 B6 4 0.5 6 0.3 50 6 4 4/4 19 6 3
106 H2-M2 CD41 plus donor BM B6 4 17.9 6 2.4 224 6 7 0/4 .100
2 9 3 105 bm12 CD41 B6 3 0.2 6 0.1 39 6 12 N.D.a N.D.
3 3 105 bm12 CD41 B6 3 0.3 6 0.1 31 6 4 N.D. N.D.
1 3 105 bm12 CD41 B6 3 7.4 6 2.4 40 6 7 N.D. N.D.
0.33 3 105 bm12 CD41 B6 3 9.9 6 3.3 66 6 13 N.D. N.D.
9 3 105 bm12 CD41 plus donor BM B6 3 13.7 6 1.8 185 6 37 N.D. N.D.
9 3 105 H2-M2 CD41 B6 3 0.3 6 0.2 86 6 11 N.D. N.D.
3 3 105 H2-M2 CD41 B6 3 1.2 6 0.8 92 6 62 N.D. N.D.
1 3 105 H2-M2 CD41 B6 3 9.4 6 1.6 79 6 18 N.D. N.D.
0.33 3 105 H2-M2 CD41 B6 3 11.8 6 1.9 74 6 20 N.D. N.D.
9 3 105 H2-M2 CD41 plus donor BM B6 3 14.1 6 3.0 388 6 131 N.D. N.D.
Purified donor cells were i.v. injected into irradiated adult host mice and the host BM nucleated cell counts (from both tibias) and spleen
weights were measured 14 days later. In a separate experiment to examine host survival, groups of four host mice were similarly treated and
observed daily for up to 3 months. Donor T-depleted BM cells were supplemented at 2 3 106 cells/mouse.
a Not determined.
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Table 3. Lethal GVHD in Heavily Irradiated bm12 but Not B6 Hosts Given H2-M2 CD41 Cells Plus H2-M2 BM Cells
Hosts Lethal Mean Survival
Experiment Donor Cells (1000cGy) GVHD Time (d)
1 106 B6 CD41 plus BM B6 0/4 .150
106 bm12 CD41 plus BM B6 4/4 81
106 H2-M2 CD41 plus BM B6 0/4 .150
2 106 bm12 CD41 plus BM bm12 0/4 .150
106 B6 CD41 plus BM bm12 4/4 80
106 H2-M2 CD41 plus BM bm12 4/4 116
Purified donor cells were injected into host mice and observed daily for signs of GVHD for up to 5 months. Mice affected with GVHD showed
severe morbidity, i.e., weight loss, ruffled fur, hunched posture, diarrhea, and lethargy, starting from about 2 weeks after donor cell injection
until death. Donor T-depleted BM cells were supplemented at 2 3 106 cells/mouse.
die from acute or chronic GVHD associated with gut either H2-M1 or B6 mice (Exp. 4; data not shown), pre-
sumably reflecting that H2-M2 mice have stronger H2-Edamage, electrolyte loss, and infection (Sprent et al.,
1990). As shown in Table 3, lethal GVHD occurred when alloreactivity than H2-M1 mice.
Despite the ability of H2-M2 mice to reject H2-A-differ-heavily irradiated bm12 hosts were injected with either
normal B6 CD41 cells plus donor BM cells or H2-M2 ent (bm12) or H2-E-different (107) skin grafts, these mice
were conspicuously unable to reject wild-type B6 graftsCD41 cells plus donor BM cells. Signs of GVHD were
apparent at 2±3 weeks postinjection and led to marked (Table 4; Figure 2A).
H2-M2.N2 mice did respond weakly against B6 graftsweight loss followed by death after 3±4 months. Similar
lethal chronic GVHD ensued when bm12 CD41 cells plus because most of these grafts shrank mildly (by about
20%) over the 8 week observation period. This weakdonor BM cells were transferred to irradiated B6 mice.
However, in marked contrast to the GVHD assays con- response, however, appeared to be directed to minor
histocompatibility (H) antigens, as similar mild graft atro-sidered earlier, transferring H2-M2 CD41 cells plus do-
nor BM cells to wild-type B6 hosts did not lead to GVHD phy was also observed with many of the B6 skin grafts
placed on control H2-M1.N2 littermates; in this respect,or death. In this situation, as in controls given syngeneic
CD41 cells, the hosts showed no obvious signs of GVHD it should be emphasized that no shrinkage was seen
when B6 skin was grafted onto H2-M2 mice back-and survived in good health for greater than 5 months
(at which time the mice were killed). crossed to B6 for six generations (H2-M2.N6) (Exp. 5). In
control experiments, B6 mice failed to reject H2-M2.N6
skin, whereas H2-M2.N2 skin was rejected at around 18
Skin Allograft Rejection by H2-M2 Hosts days (Exp. 6), presumably through recognition of multi-
Rejection of allogeneic skin grafts is a reflection of donor ple minor H antigens.
APC (Langerhans cells) migrating to the draining LN and Significantly, prior sensitization of H2-M2.N2 mice by
activating host T cells to become effector cells against i.v. injecting 2 3 107 T-depleted B6 spleen cells 2 weeks
the donor alloantigens (Rosenberg and Singer, 1992). before grafting failed to promote rejection of B6 skin.
For MHC class II±disparate skin grafts, rejection is Surprisingly, however, such priming delayed the rejec-
thought to require migration of host effector CD41 cells tion time of bm12 skin from an average of 12 days to
into the graft, local release of IFNg by the T cells leading 27 days, perhaps reflecting ªcold target competitionº
to upregulation of class II expression on keratinocytes, (suppression) at the APC level by primed low-affinity
followed by destruction of keratinocytes through CD41 B6-reactive cells (Waldmann and Cobbold, 1998) (Exp.
cell effector function (Rosenberg et al., 1989, 1990). 7). Comparable priming of H2-M2 mice with T-depleted
To test the capacity of H2-M2 CD41 cells to mediate bm12 spleen cells also did not affect the acceptance
graft rejection, H2-M2 mice (H2b (B6 3 129)F2 back- of B6 skin grafts; in this situation, however, priming
crossed twice to B6 [designated H2-M2.N2]) were accelerated the rejection time of bm12 skin grafts by 1
grafted with B6 and bm12 tail skin onto the lateral tho- day (Exp. 7). Grafting a mixture of B61bm12 skin onto
racic region and the fate of the grafts monitored. As H2-M2.N6 mice for a second time also did not promote
controls, H2-M1.N2 littermates were grafted with B6 and rejection of B6 grafts. For both primary and secondary
bm12 skin. Consistent with past work on the B6/bm12 B6 skin grafts, the grafts showed no sign of rejection
combination (Rosenberg and Singer, 1992), bm12 skin throughout a 100 day observation period; for bm12
grafts placed on H2-M1.N2 littermates were rejected grafts, rejection of secondary bm12 grafts was acceler-
within 14 days, whereas syngeneic B6 skin grafts were ated by 4 days relative to primary grafts (Exp. 5).
not rejected (Table 4). Like H2-M1 mice, H2-M2.N2 mice To prove that rejection of allogeneic bm12 grafts by
readily rejected both bm12 grafts (in 12 days) and H2- H2-M2 mice was mediated by CD41 cells, H2-M2.N2
heterozygous (B6 3 bm12)F1 grafts (in 17 days). H2- mice depleted of CD41 cells (by thymectomy and re-
M2.N2 mice also rejected grafts expressing the weak peated injection of anti-CD4 MAb GK1.5) were grafted
class II H2-E alloantigen, irrespective of whether these with bm12 skin. These mice failed to reject bm12 grafts,
grafts were host H2-Ab1 (107) (Widera et al., 1987) or whereas control H2-M2.N2 mice selectively depleted of
host H2-Ab2 (H2-A2 107) (Table 4; Exp. 4). This was CD81 cells promptly rejected bm12 grafts within 2 weeks
(Exp. 8; Figure 2B). These findings confirm that CD41surprising because these grafts were not rejected by
Function of T Cells Selected by a Single Ligand
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Table 4. Rejection of bm12 but Not B6 Skin Grafts by H2-M2 Mice
Experiment Host Mice n Host Treatment Donor Skin Mean Rejection Time (d)a
1 H2-M2.N2 4 none B6 1 bm12 B6: .50, bm12: 14
H2-M2.N2 7 none B6 1 bm12 B6: .50, bm12: 12
2 H2-M1.N2 4 none B6 1 bm12 B6: .50, bm12: 13
H2-M2.N2 4 none B6 1 bm12 B6: .50, bm12: 12
3 H2-M2.N2 4 none B6 1 (B6 3 bm12)F1 B6: .50, (B6 3 bm12)F1: 17
4 H2-M1.N2 3 none 107b 1 H2-A2 107b 107: .50, H2-A2 107: .50
H2-M2.N2 4 none 107 1 H2-A2 107 107: 27, H2-A2 107: 27
5 H2-M2.N6 4 none B6 1 bm12 B6: .50, bm12: 14
H2-M2.N6 4 none B6 1 bm12 B6: .50, bm12: 15
H2-M2.N6 4 grafted with B6 1 bm12c B6 1 bm12 B6: .50, bm12: 10
6 B6 4 none H2-M2.N2 1 bm12 H2-M2.N2: 18, bm12: 15
B6 4 none H2-M2.N6 1 bm12 H2-M2.N6: .50, bm12: 15
7 H2-M2.N2 4 primed w/B6 spleend B6 1 bm12 B6: .50, bm12: 27
H2-M2.N2 4 primed w/bm12 spleend B6 1 bm12 B6: .50, bm12: 11
8 H2-M2.N2 4 Atx & CD4-depletione B6 1 bm12 B6: .50, bm12: .50
H2-M2.N2 4 Atx & CD8-depletione B6 1 bm12 B6: .50, bm12: 14
Host mice were grafted with donor mice tail skin and observed daily for up to 8 weeks. Rejection was scored as the day scab formation
became first visible, which was usually within 2±3 days prior to complete rejection of the graft. H2-M2.N2 and H2-M2.N6 mice are original
H2-M2 mice in (B6 3 129)F2 background backcrossed two or six times to B6, respectively.
a The incidence of graft rejection was 100% for the groups showing rapid (,50 d) rejection and 0% for the other (.50 d) groups.
b Whereas B6 mice have an H2-Ab E2 phenotype, 107 mice are H2-Ab E1 B6 mice; 107 mice express a transgenic H2-Ek a-chain, which allows
expression of the endogenous H2-Eb b-chain plus the transgenic H2-Ek a-chain. H2-A2 107 mice were obtained by backcrossing 107 mice
to H2-A-deficient mice, thus generating H2-A2 Eb/k mice.
c Mice were grafted with B6 1 bm12 skin 50 d prior to grafting the secondary grafts. The primary B6 grafts remained intact during the 50 d
observation period for the secondary grafts.
d Hosts were first thymectomized and depleted of CD81 cells by injecting anti-CD8 (YTS-169) ascites fluid (50 ul/day for 3 days), and then
primed by i.v. injecting 2 3 107 T cell-depleted B6 or bm12 spleen cells 1 week later. The mice were grafted 2 weeks later.
e Depletion of the indicated T cell subset was performed by injecting adult thymectomized (Atx) mice with anti-CD4 (GK1.5) or anti-CD8 (YTS-
169) mAb ascites fluid (50 ul/day for 3 days). T cell±depleted mice were bled 7 days after the last ascites fluid injection and contained ,1%
of the depleted T cells; mice were grafted the next day.
cells mediate bm12 graft rejection with little or no contri- epidermal layer of the bm12 (bm12→H2-M2) grafts, pre-
sumably keratinocytes, showed strong upregulation ofbution by CD81 cells (Rosenberg et al., 1987).
MHC class II molecules; such staining was well above
the weak staining found in control bm12→bm12 graftsLack of MHC Class II Upregulation
on B6 Skin Grafts (data not shown). The failure of keratinocytes in B6→
H2-M2 grafts to upregulate MHC class II molecules cor-As mentioned above, rejection of MHC class II±disparate
skin grafts requires upregulation of MHC class II mole- related with a lack of infiltrating host T cells. Thus, in
H2-M2 hosts, staining serial sections showed that hostcules on the keratinocytes, a process which is believed
to be mediated by IFNg released from infiltrating host Thy-1.11 CD41 cells were prominent in bm12 grafts but
not in B6 skin grafts (Figure 2C).CD41 cells (Rosenberg et al., 1989, 1990). Since B6 APC
induced only low levels of IFNg synthesis by H2-M2
CD41 cells in vitro (Figure 1A), we sought to determine Discussion
histologically whether the keratinocytes in B6 skin
grafted onto H2-M2 hosts showed upregulation of MHC We and others showed previously that CD41 cells from
H2-M2 mice give conspicuously high primary MLR toclass II molecules. For this purpose, B6 and bm12 (both
Thy-1.21) skin was grafted onto Thy-1.11 H2-M2 mice, wild-type B6 APC in vitro (Fung-Leung et al., 1996; Mar-
tin et al., 1996; Miyazaki et al., 1996). In fact, measuringa combination that also allowed identification of the
infiltrating host T cells. For controls, B6 and bm12 skin precursor frequencies indicated that around 40% of
H2-M2 CD41 cells entered cell cycle in response to B6were grafted onto Thy-1 congeneic B6.PL (Thy-1.11)
and bm12 hosts, respectively. The biopsies of the grafts APC in vitro, which is far higher than for the response
of normal CD41 cells to allo class II differences (Surhwere taken on day 9, just prior to rejection of bm12
grafts by H2-M2 (H2-M2.N2) mice. et al., 1997). Since H2-M2 CD41 cells also give strong
responses to allo class II differences, e.g., to bm12, weAs shown in Figure 2C, staining frozen skin sections
revealed a marked difference between the B6 and bm12 expected the responses to B6 and bm12 to be qualita-
tively similar. This, however, was not the case. The unex-skin grafted onto H2-M2 mice in terms of MHC class II
expression. As detected with MAb M5/114, which stains pected finding was that, as manifested by susceptibility
to blocking with MAbs specific for TCR, class II, andH2-Ab and H2-Abm12 molecules equally, B6(B6→H2-M2)
grafts contained weakly staining H2-A1 cells scattered CD4, the affinity/avidity of H2-M2 CD41 cells for B6 was
substantially less than for bm12. In line with this finding,in the dermis but not in the epidermis, as compared to
the background level of staining in the control B6(B6→ in vitro production of three cytokines, IL-2, IL-4, and
IFNg, by H2-M2 CD41 cells was considerably lower withB6) grafts. In striking contrast, most cells in the basal
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Figure 2. Rejection of bm12 but Not B6 Skin Grafts by H2-M2 Mice
(A) A representative H2-M2 mouse grafted 11 days before with B6 (*) and bm12 (x) tail skin: the B6 skin graft is intact, whereas the bm12
graft is undergoing acute rejection with clearly visible inflammation and scabbing.
(B) A thymectomized, CD4-depleted H2-M2 mouse grafted 16 days before with B6 (*) and bm12 (x) tail skin: both B6 and bm12 grafts are
intact. Thymectomy and depletion of CD41 cells were performed as described in the Experimental Procedures.
(C) Immunohistochemical analysis of skin grafts placed on H2-M2 mice. Grafts of B6 (middle column) and bm12 (right column) skin were
grafted adjacent to each other onto an H2-M2 host; as a control, B6 skin was grafted onto B6 mice (left column). Biopsies were taken 9 days
later for cryostat sections. Sections were stained for the expression of MHC class II (using MAb M5/114, which stains both H2-Ab and H2-
Abm12), CD4, and Thy-1.1 molecules. To identify infiltrating host T cells, the host H2-M2 mice were backcrossed to a Thy-1.11 (B6.PL) background,
whereas the donor grafts were from Thy-1.12 (B6, Thy-1.21) mice. As controls, B6 and bm12 skin were grafted separately onto Thy-1 congenic
B6.PL (B6→B6) (left column) and bm12 (data not shown) hosts, respectively; both types of grafts showed similiar negative staining. The
staining pattern shown is representative of three different grafts.
B6 APC than with bm12 APC, even though proliferative the host spleen is due largely to proliferation of host
myeloid cells (Simonsen, 1962), probably reflecting pro-responses were as high or higher with B6 as with bm12
APC; for another cytokine, IL-3, responses to B6 and duction of IL-3 and related myeloid growth factors by
the donor T cells. Since H2-M2 CD41 cells producedbm12 were equivalent. Before considering possible ex-
planations for the low affinity of H2-M2 CD41 cells for substantial quantities of IL-3 in response to either B6
or bm12 APC in vitro, the potency of H2-M2 CD41 cellsB6, the in vivo responses of H2-M2 CD41 cells to B6
versus bm12 require comment (Table 5). in causing splenomegaly in both B6 and bm12 neonatal
hosts is therefore not surprising. H2-M2 CD41 cells alsoIn two in vivo assays for GVHD, the reactivity of H2-M2
CD41 cells for B6 and bm12 was quite similar. Thus, in responded strongly to B6 in terms of inducing destruc-
tion of host BM cells in lightly irradiated B6 mice. Basedthe Simonsen assay in which T cells are transferred to
unirradiated neonates, even small numbers of H2-M2 on prior studies with the B6/bm12 combination (Sprent
et al., 1994), destruction of host BM cells is class II-CD41 cells induced marked splenomegaly in both B6
and bm12 hosts. In this situation, the enlargement of restricted and directed to stem cells (and other class
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cells were unresponsive to B6 may be heavily dependentTable 5. Summary of Effector Functions Mediated by H2-M2
on the production of inflammatory cytokines such asCD41 Cells
IFNg; because of the low affinity of H2-M2 CD41 cells
Stimulated by
for B6 APC, the production of these cytokines is very
Types of Response B6 bm12 limited, especially under in vivo conditions. The effector
function of CD41 cells is thus inadequate. This raisesMLR (in vitro proliferation) 111 111
the key issue of why H2-M2 CD41 cells have low affinityIL-2, IL-4, and IFNg secretion 1 111
IL-3 secretion 111 111 for B6. Here, there are several possibilities.
Splenomegaly in unirradiated neonates 111 111 A priori, one might argue that the specificity of H2-M2
Destruction of host marrow in lightly 111 111 CD41 cells for B6 and bm12 is essentially different. Thus,
irradiated adults
with bm12 APC, one can envisage that H2-M2 CD41Lethal GVHD in heavily irradiated adults 2 111
cells have potential joint specificity for two sets of li-given donor BM cells
gands, namely the various self-peptides bound toSkin graft rejection 2 111
H2-Abm12 molecules, and bm12-unique H2-A epitopes
expressed on the a-helices around the peptide-binding
II1 cells); donor BM-derived cells are spared, implying groove. With B6 APC, by contrast, H2-Ab epitopes are
that the destruction of stem cells reflects direct cell autologous (B6 and H2-M mice are both H2-Ab), and the
contact rather than local release of toxic cytokines. Al- specificity of H2-M2 CD41 cells for B6 is presumably
though the mechanism of cell destruction in this assay directed predominantly to the array of self-peptides
is still not fully understood, both perforin- and Fas/FasL- bound in the H2-Ab groove. Therefore, for H2-M2 CD41
mediated lysis may be involved (Braun et al., 1996; Baker cells responding to B6, it is conceivable that recognition
et al., 1997; Hattori et al., 1998). Based on the present of peptides alone is insufficient to mediate skin graft
results, such lysis can apparently be mediated by low- rejection. This possibility is unlikely because purified
affinity CD41 cells. CD41 cells are able to mediate rejection of MHC-identi-
In marked contrast to the above GVHD assays, H2-M2 cal skin expressing multiple minor H differences (Rosen-
CD41 cells showed no detectable capacity to cause berg et al., 1987).
lethal GVHD when transferred with donor BM cells to A more likely possibility is that the low affinity of
heavily irradiated adult B6 mice; with bm12 hosts, by H2-M2 CD41 cells for B6 APC is a reflection of thymic
contrast, all of the recipients developed lethal GVHD. In selection. Here, one can consider two broad scenarios.
this assay, GVHD appears to be largely a reflection of First, binding of CLIP by H2-Ab molecules in H2-M2
gut damage caused by release of toxic cytokines such mice may not be absolute and thus allow significant
as TNFa (Piguet et al., 1987; Hattori et al., 1998). Hence, expression of self-peptides; expression of these pep-
the failure of H2-M2 CD41 cells to produce lethal GVHD tides in the thymus (and elsewhere) could thus be suffi-
in B6 hosts may reflect low production of cytokines. For cient to delete T cells with high affinity for the peptides.
TNFa, we were unable to test this idea directly because, This possibility merits consideration, because the H2-A
both for B6 and bm12 APC, TNFa production by H2-M2 molecules on H2-M2 APC do seem to express very low
CD41 cells in vitro was too low to quantitate. levels of certain self-peptides (Grubin et al., 1997;
As for the above lethal GVHD assay, H2-M2 mice were Tourne et al., 1997). Nevertheless, the diversity of these
totally unable to induce rejection of B6 skin grafts, even peptides appears to be quite limited (Grubin et al., 1997).
though bm12 grafts were rapidly rejected. Significantly, Hence, one would have to argue that the particular H2-
the failure of H2-M2 mice to reject B6 skin grafts could A-associated self-peptides displayed on H2-M2 APC
not be abrogated by priming with either B6 or bm12 are the dominant epitopes expressed on wild-type B6
spleen cell injections or by applying subsequent skin APC and are crucial for eliciting IFNg production, etc.
grafts. In accounting for why H2-M2 mice failed to reject Although this possibility seems unlikely, the notion that
B6 grafts, it is notable that histological examination of expression of self-peptides in H2-M2 mice is ªleakyº
the grafts revealed very limited infiltration of the grafts and leads to significant negative selection to these pep-
with host CD41 cells and no detectable upregulation of tides cannot be excluded. On this point, a key issue is
host class II in the epidermis; by contrast, bm12 grafts whether B6 skin grafts can be rejected by the AbEaA2Ii2
showed marked T cell infiltration and prominent class transgenic line in which virtually all H2-Ab molecules
II upregulation. Since rejection of class II different skin express a single covalently linked peptide (Ignatowicz
grafts appears to be crucially dependent on IFNg-medi- et al., 1996; Grubin et al., 1997). Significantly, preliminary
ated upregulation of class II expression on keratinocytes experiments have shown that these mice do not reject
(Rosenberg et al., 1989, 1990), the failure of H2-M2 CD41 B6 skin grafts. This finding thus makes it unlikely that
cells to reject B6 grafts correlates well with the limited failure of H2-M2 mice to reject B6 skin grafts reflects
production of IFNg by H2-M2 CD41 cells responding to negative selection to non-CLIP peptides.
B6 APC in vitro. Nevertheless, it is surprising that B6 The second scenario, which we favor, is that the low
grafts on H2-M2 mice showed only minimal infiltration affinity of H2-M2 CD41 cells for wild-type B6 APC is a
by host CD41 cells. One possible explanation here is reflection of aberrant thymic selection, i.e., selection
that the affinity of H2-M2 CD41 cells responding to B6 directed to a high concentration of a single ligand, CLIP/
APC is below the threshold required for upregulating H2-Ab. Contact with these complexes on thymic epithe-
skin-homing receptors (Berg et al., 1991; Teraki and lium would be expected to induce positive selection of
Picker, 1997). This possibility is being investigated. CD41 cells with a broad range of affinities for CLIP/
H2-Ab, varying from low (but significant) to high; negativeAs argued above, the assays in which H2-M2 CD41
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(anti-Thy-1), and M5/114 (anti-H2-A) (Surh et al., 1997). Anti-Vb8 IgMselection would then delete the high-affinity cells, leav-
MAb MR5-7, which does not induce proliferation of Vb81 T cells ining the low-affinity cells to be exported to the periphery.
soluble form, was obtained from Dr. Osami Kanagawa (WashingtonBut why would the exported T cells have low affinity for
Univ, St. Louis, MO). The following pairs of MAbs for detecting
the peptides expressed on wild-type B6 APC? There mouse cytokines were purchased from Pharmingen (San Diego,
are at least two possibilities. CA): JES6-1A12 and biotinylated JES6-5H4 for IL-2, MP2-8F8 and
biotinylated MP2-43D11 for IL-3, 11B11 and biotinylated BVD6-First, because of crossreactivity, T cells with potential
24G2 for IL-4, R4-6A2 and biotinylated XMG1.2 for IFNg, and G281-high affinity for the low concentrations of various self-
2626 and biotinylated MP6-XT3 for TNFa. Other reagents purchasedpeptides found on normal B6 APC might be deleted in
were biotinylated OX-7 MAb (anti-Thy-1.1) (Pharmigen) and biotinyl-the thymus of H2-M2 mice via recognition of a high
ated anti-rat IgG (H1L) Ab and alkaline phosphatase-streptavidin
concentration of CLIP. The assumption here is that, for from Jackson ImmunoResearch (West Grove, PA). Cy5-conjugated
negative selection, a single peptide expressed at a very GK1.5 (anti-CD4) MAb was generated as previously described (Surh
et al., 1997). Purified CD41 cells were obtained by treating LN cellhigh level can be recognized by a diverse repertoire of
suspensions with a cocktail of anti-CD8, anti-HSA, and anti-MHCT cells, thus leading to polyclonal deletion. This assump-
class II MAbs plus C9 and then panning on anti-CD4-coated plates.tion is reasonable because, at least for positive selec-
T-depleted splenocytes were obtained by treating spleen cells withtion, CLIP/H2-Ab complexes do indeed select a diverse
anti-Thy-1 MAb plus C9. T-depleted BM cells were produced by
T cell repertoire (Sant'Angelo et al., 1997; Surh et al., killing BM cells with anti-Thy-1 MAb and C9.
1997; Tourne et al., 1997).
Second, leaving aside negative selection, thymocytes In Vitro T Cell Responses
Mixed-lymphocyte reactions (MLR) were set up by incubating 1.5 3with the potential to recognize wild-type peptides on
105 purified H2-M2 CD41 cells with 7 3 105 B6 or bm12 T-depletedB6 APC with high affinity may simply fail to undergo
irradiated (2000 cGy) spleen cells in 96-well plates for 3±4 dayspositive selection in the H2-M2 thymus; thus, the cells
using culture conditions as described (Surh et al., 1997). To measureundergoing positive selection to a high concentration
cell proliferation, cultures were pulsed with 1 mCi 3H-TdR/well 8 hr
of CLIP/H2-Ab may have only limited reactivity for the prior to harvest. To measure cytokine release by responder T cells,
low concentrations of peptides found on normal B6 APC. supernatants from similar cultures set up at the same time were
Because of altered positive selection, the B6-reactivity harvested and analyzed for the presence of various cytokines using
ELISA procedures as recommended by the MAbs manufacturerof H2-M2 CD41 cells would then be largely restricted
(Pharmingen). Inhibition of proliferative responses with anti-CD4to low-affinity cells, high-affinity cells having failed to
(GK1.5), anti-Vb8 (MR5-7), or anti-class II (Y3P) MAbs was performedundergo positive selection. Without further information
by adding titrating dilutions of the MAbs at the beginning of the
it is difficult to choose between these two possibilities. MLR cultures. The cultures were harvested 3 days later; 3H-TdR
Whatever the explanation, the data in this paper show was added 8 hr prior to the harvest. The MAbs were purified by
that thymic selection directed to a high concentration ammonium sulfate precipitation of ascites fluids as described (Mi-
shell and Shiigi, 1980). MR5-7 MAb did not induce proliferation ofof a single ligand generates a post-thymic CD41 cell
Vb81 T cells when cultured with whole spleen cells from H2-M2 orrepertoire that is highly reactive to self-peptides, but
H2-M1 mice at any of the concentrations used for inhibition.with only low affinity. Because of this altered specificity,
the selected CD41 cells are strongly reactive in some
Induction of GVHD
assays (e.g., MLR) but totally unreactive in others (e.g., Three different assays were used to measure the capacity of H2-M2
skin graft rejection). Studies on the ªsplit toleranceº of versus normal CD41 cells to induce GVHD in secondary B6 versus
T cells generated in BM chimeras are consistent with bm12 hosts. First, induction of splenomegaly (the Simonsen assay)
was assessed by injecting purified CD41 cells i.v. into neonatal hoststhis interpretation (Gao et al., 1990; Kosaka and Sprent,
(Simonsen, 1962). The splenomegaly index was measured 10 days1993).
later by dividing the H2-M2 CD41 cell-injected host spleen-to-body
weight ratio by the control B6 CD41 cell-injected host spleen-to-Experimental Procedures
body weight ratio. Second, the capacity to induce host bone marrow
(BM) aplasia was assessed by injecting purified CD41 cells i.v. with-Animals
out donor BM cells into sublethally irradiated (600 cGy) adult hostsH2-M-deficient mice on a C57BL/6 (B6, H2b) background were bred
(Sprent et al., 1994). The number of nucleated cells in host BM andand maintained at the Scripps Research Institute (TSRI). Most of
spleen weights were measured 14 days later. Some of the injectedthe H2-M2 mice used in the experiments originated from (B6 3
hosts were set aside for daily observation for GVHD. Third, the129)F2 (H-2b) mice backcrossed to B6 for two generations (desig-
capacity to induce lethal GVHD was assessed by injecting CD41nated as H2-M2.N2) (Fung-Leung et al., 1996). Some of the H2-M2
cells i.v. with donor BM into lethally irradiated (1000cGy) adult micemice used for skin grafting and GVHD experiments were from the
(Sprent et al., 1990). Host mice were observed for signs of GVHDsixth generation B6 backcross (designated as H2-M2.N6). Thy-1.11
(severe weight loss, hunched posture, diarrhea, and lethargy) for aH2-M2 mice were obtained by backcrossing twice to B6.PL (H2b,
period of up to 6 months. For lethal GVHD, death was defined asThy-1.1) mice. B6, B6.bm12 (bm12) and (B6 3 bm12)F1 mice were
the time at which the mice were no longer able to take food andeither purchased from the Jackson Laboratory (Bar Harbor, ME) or
water, at which time the mice were sacrificed to prevent suffering.from the rodent breeding colony at TSRI. 107 mice (H2-Ab, E1 B6
As controls for all three types of assays, H2-M2 CD41 cells weremice expressing transgenic H2-Ea chain) (Widera et al., 1987) and
i.v. injected into autologous H2-M2 mice.H2-A-deficient H2-E1 107 mice were provided by Dr. David Lo
(TSRI). Vb8-transgenic H2-M2 mice (Sant'Angelo et al., 1997) were
Skin Grafting and Immunohistochemistryprovided by Dr. Derek Sant'Angelo (Yale Univ., New Haven, CT),
Donor tail skin was grafted as previously described (Rosenberg,and AbEpIi2A2 mice (Ignatowicz et al., 1996) in (B6 3 129)F2 (H-2b)
1991). In brief, mice anesthetized with avertin were grafted with abackground were provided by Dr. Leszek Ignatowicz (Med. College
z5 3 5 mm piece of donor tail skin onto the lateral thoracic regionGeorgia, GA).
(depleted of hair and epidermis). In most cases, single pieces of
skin from two different donors were grafted adjacent to each other.Antibodies and Cell Purification
Bandages were removed 7±8 days later and the grafts were ob-The following MAbs were previously described: Y3P (anti-H2-Ab),
served daily for up to 50 days. Some of the host H2-M2 mice wereGK1.5 (anti-CD4), RL172 (anti-CD4), 3.168 (anti-CD8), YTS169 (anti-
CD8), 28-16-8s (anti-H2-Ab), J11d (anti-HSA), J1j (anti-Thy-1.2), T24 adult thymectomized as described (Mishell and Shiigi, 1980) and
Function of T Cells Selected by a Single Ligand
91
depleted of host CD41 or CD81 cells by daily injection of 50 ml of Grubin, C.E., Kovats, S., deRoos, P., and Rudensky, A.Y. (1997).
Deficient positive selection of CD4 T cells in mice displaying alteredanti-CD4 (GK1.5) or anti-CD8 (YTS169) ascites fluid, respectively,
for 3 days. repertoire of MHC class II-bound self peptides. Immunity 7, 197±208.
To characterize skin rejection histologically, B6 (Thy-1.21) and Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M.,
bm12 (Thy-1.21) skin was grafted onto Thy-1.11 H2-M2 mice. Oshimi, K., Kayagaki, N., Yagita, H., and Okumura, K. (1998). Differ-
Grafted skin biopsies were taken 9±10 days later, quickly frozen, ential effects of anti-Fas ligand and anti-tumor necrosis factor alpha
and cryostat sections stained for expression of H2-A (M5/114), CD4 antibodies on acute graft-versus-host disease pathologies. Blood
(GK1.5), and Thy-1.1 (OX-7) as previously described (Surh et al., 91, 4051±4055.
1992). In brief, after fixation with acetone, sections were incubated Hogquist, K.A., Jameson, S.C., Heath, W.R., Howard, J.L., Bevan,
with optimal dilutions of the MAbs overnight at 48C. For M5/114 and M.J., and Carbone, F.R. (1994). T cell receptor antagonist peptides
GK1.5, sections were then washed and incubated for 1 hr with induce positive selection. Cell 76, 17±27.
biotinylated anti-rat IgG (Jackson ImmunoResearch), washed, and
Ignatowicz, L., Kappler, J., and Marrack, P. (1996). The repertoirethen incubated with alkaline phophatase (AP)-conjugated steptavi-
of T cells shaped by a single MHC/peptide ligand. Cell 84, 521±529.din (Jackson ImmunoResearch); biotinylated OX-7 was detected
Jameson, S.C., and Bevan, M. (1998). T-cell selection. Curr. Opin.using only AP-streptavidin. The sections were subsequently devel-
Immunol. 10, 214±219.oped with an AP substrate Fast Violet as described (Surh et al.,
1992). Jameson, S.C., Hogquist, K.A., and Bevan, M.J. (1995). Positive
selection of thymocytes. Annu. Rev. Immunol. 13, 93±126.
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